Short Interest in iShares Health Innovation Active ETF (NYSEARCA:BMED) Grows By 621.1%

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 8,033 shares, an increase of 621.1% from the July 15th total of 1,114 shares. Currently, 2.2% of the shares of the stock are sold short. Based on an average trading volume of 1,025 shares, the days-to-cover ratio is currently 7.8 days.

iShares Health Innovation Active ETF Price Performance

BMED remained flat at $32.33 during midday trading on Wednesday. 966 shares of the company’s stock were exchanged, compared to its average volume of 3,500. The company has a market cap of $11.64 million, a price-to-earnings ratio of 24.91 and a beta of 0.73. The company’s 50 day moving average is $30.21 and its 200-day moving average is $29.62. iShares Health Innovation Active ETF has a 1 year low of $24.96 and a 1 year high of $32.35.

Hedge Funds Weigh In On iShares Health Innovation Active ETF

An institutional investor recently bought a new stake in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. acquired a new position in iShares Health Innovation Active ETF (NYSEARCA:BMED) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF as of its most recent SEC filing.

About iShares Health Innovation Active ETF

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.